Personalized, at-home, adaptive deep brain stimulation is safe and effective for patients with moderate-to-advanced Parkinson ...

Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy ...

A recent trial published in the Journal of American Medical Association found that subthalamic deep brain stimulation (DBS) ...

On Saturday, Oct. 11, HSHS St. Elizabeth’s Hospital will host a free educational seminar to raise awareness of the benefit ...

At the end of the operation, the neurosurgeon declared that he had never before encountered a patient so calm and at ease ...

Medtronic (NYSE: MDT) today announced study results backing its adaptive DBS algorithm for personalized therapy in ...

It is estimated that one-third of the 50 million people worldwide with epilepsy are resistant to anti-seizure medications.

Deep brain stimulation is a surgical brain therapy used to treat symptoms of movement disorders such as dystonia, Parkinson’s ...

The INTREPID study group, a team of 49 researchers from 30 academic and medical institutions, reports on sustained five-year ...

One-third of epilepsy patients are resistant to medication. Deep brain stimulation of the centromedian nucleus (CM) is a ...

Visual symptoms in Parkinson’s disease may remain largely unchanged despite treatment with levodopa or deep brain stimulation ...